A chemogenomic approach to drug discovery: focus on cardiovascular diseases.

Drug Discov Today

Chemogenomics Laboratory, Research Unit on Biomedical Informatics, Institut Municipal d'Investigació Mèdica and Universitat Pompeu Fabra, Parc de Recerca Biomèdica, Doctor Aiguader 88, 08003 Barcelona, Catalonia, Spain.

Published: May 2009

AI Article Synopsis

Article Abstract

References to individual protein targets and bioactive small molecules associated with cardiovascular diseases can be found in multiple bibliographic sources. From mining these sources, a highly curated list of 214 cardiovascular targets was collected and organised using functional classification schemes for the main protein families of therapeutic relevance, namely, enzymes, G-protein-coupled receptors, ion channels, and nuclear receptors. This list was then used to interrogate annotated chemical libraries and extract a chemical space of 44032 small molecules connected to 160 targets. Some of these bioactive ligands were also found to have affinity for an additional set of 421 proteins not linked originally to cardiovascular diseases, thus constituting a valuable indirect source to complete the cardiovascular target space and infer a potential off-cardiovascular target space.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2009.02.010DOI Listing

Publication Analysis

Top Keywords

cardiovascular diseases
12
targets bioactive
8
small molecules
8
target space
8
cardiovascular
5
chemogenomic approach
4
approach drug
4
drug discovery
4
discovery focus
4
focus cardiovascular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!